Amylyx Pharmaceuticals, Inc. — Institutional Ownership
Which tracked institutions hold AMLX, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
24
Funds holding
$528121549
Total value held
Buying
20 added/new · 4 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $158534442 | 8827085 | -1751 | -0.02% |
| 2 | Janus Henderson Group Plc | $69256554 | 4986073 | +4986073 | NEW BUY |
| 3 | Morgan Stanley | $56229311 | 3130808 | +955261 | +43.91% |
| 4 | Franklin Resources Inc | $52986040 | 2950225 | +688656 | +30.45% |
| 5 | Goldman Sachs Group Inc | $51333972 | 2858239 | +232248 | +8.84% |
| 6 | State Street Corp | $46755933 | 2603337 | +240176 | +10.16% |
| 7 | Jpmorgan Chase & Co | $34921895 | 1863650 | +1703987 | +1067.24% |
| 8 | Northern Trust Corp | $14938051 | 831740 | +51832 | +6.65% |
| 9 | Bank Of America Corp /De/ | $14760265 | 821841 | -508848 | -38.24% |
| 10 | Federated Hermes, Inc. | $8301202 | 462205 | +462205 | NEW BUY |
| 11 | Bank Of New York Mellon Corp | $4928853 | 274435 | +23331 | +9.29% |
| 12 | Ubs Group Ag | $4882983 | 271881 | +271881 | NEW BUY |
| 13 | Invesco Ltd. | $2513358 | 139942 | +139942 | NEW BUY |
| 14 | Wells Fargo & Company/Mn | $2301823 | 128164 | +53081 | +70.70% |
| 15 | Ameriprise Financial Inc | $2253693 | 125484 | +125484 | NEW BUY |
| 16 | Citigroup Inc | $1233565 | 68684 | +30652 | +80.60% |
| 17 | Barclays Plc | $1010394 | 56258 | -915596 | -94.21% |
| 18 | Sei Investments Co | $354710 | 19750 | -65529 | -76.84% |
| 19 | Prudential Financial Inc | $271376 | 15110 | +990 | +7.01% |
| 20 | Royal Bank Of Canada | $263000 | 14649 | +2266 | +18.30% |
| 21 | Us Bancorp \De\ | $65357 | 3639 | +1576 | +76.39% |
| 22 | Fifth Third Bancorp | $17457 | 972 | +217 | +28.74% |
| 23 | Pnc Financial Services Group, Inc. | $7292 | 406 | +123 | +43.46% |
| 24 | Amalgamated Financial Corp. | $23 | 1763 | +1763 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.